Wenhao Yu

No.107 Wenhua West Road
Jinan, 250012, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

GMFB promotes lung adenocarcinoma progression by activating the MAPK/ERK signaling pathway.

GMFB promotes lung adenocarcinoma progression by activating the MAPK/ERK signaling pathway.

Journal: Molecular and cellular biochemistry

Published: December 15, 2025

NUF2 interacts with BUB3 and drives lung adenocarcinoma progression through activation of the NF-κB pathway.

NUF2 interacts with BUB3 and drives lung adenocarcinoma progression through activation of the NF-κB pathway.

Journal: World journal of surgical oncology

Published: November 03, 2025

Integrated analysis and functional validation reveal KCNQ1 tumor suppressor targeting by dahuang Zhechong Pills via cuproptosis modulation in colorectal cancer.

Integrated analysis and functional validation reveal KCNQ1 tumor suppressor targeting by dahuang Zhechong Pills via cuproptosis modulation in colorectal cancer.

Journal: Computational biology and chemistry

Published: June 27, 2025

MYSM1 promotes lung adenocarcinoma progression via TRAF2/3-mediated activation of MAPK and non-canonical NF-κB pathways.

MYSM1 promotes lung adenocarcinoma progression via TRAF2/3-mediated activation of MAPK and non-canonical NF-κB pathways.

Journal: NPJ precision oncology

Published: May 26, 2025

RECQL4 promotes the malignant progression of lung adenocarcinoma through the YBX1/G3BP1-mediated NF-κB signaling pathway.

RECQL4 promotes the malignant progression of lung adenocarcinoma through the YBX1/G3BP1-mediated NF-κB signaling pathway.

Journal: Cell death discovery

Published: March 10, 2025

GINS1 facilitates the development of lung adenocarcinoma via Wnt/β-catenin activation.

GINS1 facilitates the development of lung adenocarcinoma via Wnt/β-catenin activation.

Journal: World journal of surgical oncology

Published: November 24, 2024

TFIIB-related factor 2 inhibits lung squamous carcinoma cell apoptosis through SLC8A3-mediated mitochondrial homeostasis.

TFIIB-related factor 2 inhibits lung squamous carcinoma cell apoptosis through SLC8A3-mediated mitochondrial homeostasis.

Journal: Cell death & disease

Published: November 03, 2024

Unveiling hotspots of emerging research in the miRNA-related mechanism underlying cancer through comprehensive bibliometric analysis with implications for precision medicine and non-invasive diagnostics.

Unveiling hotspots of emerging research in the miRNA-related mechanism underlying cancer through comprehensive bibliometric analysis with implications for precision medicine and non-invasive diagnostics.

Journal: Frontiers in oncology

Published: November 01, 2024

The predictive value of intratumoral tertiary lymphoid structures on the response to immunotherapy in cancer patients: a systematic review and meta-analysis.

The predictive value of intratumoral tertiary lymphoid structures on the response to immunotherapy in cancer patients: a systematic review and meta-analysis.

Journal: BMC cancer

Published: September 30, 2024

Prognostic and clinicopathological significance of tertiary lymphoid structure in non-small cell lung cancer: a systematic review and meta-analysis.

Prognostic and clinicopathological significance of tertiary lymphoid structure in non-small cell lung cancer: a systematic review and meta-analysis.

Journal: BMC cancer

Published: April 22, 2024

Peptidyl-prolyl isomerase F as a prognostic biomarker associated with immune infiltrates and mitophagy in lung adenocarcinoma.

Peptidyl-prolyl isomerase F as a prognostic biomarker associated with immune infiltrates and mitophagy in lung adenocarcinoma.

Journal: Translational lung cancer research

Published: April 17, 2024

Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components.

Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components.

Journal: World journal of surgical oncology

Published: November 26, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026